论文信息 - TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer. - 字舞流文

TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.

J. Korbel | C. Plass | G. Sauter | B. Brors | T. Schlomm | S. Steurer | C. Wittmer | R. Simon | S. Minner | M. Tsourlakis | M. Graefen | H. Huland | J. Weischenfeldt | P. Tennstedt | A. Krohn | C. Koop | Meike Adam | P. Mayer | Daniel Ospina-Klinck | A. A. Tehrani

[1] J. Korbel,et al. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions , 2013, Modern Pathology.

[2] G. Sauter,et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. , 2013, Cancer research.

[3] V. Beneš,et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. , 2013, Cancer cell.

[4] C. Plass,et al. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. , 2012, The American journal of pathology.

[5] S. Varambally,et al. Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer , 2009, Science.

[6] H. D. de Koning,et al. Gleason score, age and screening: Modeling dedifferentiation in prostate cancer , 2006, International journal of cancer.

[7] Ziding Feng,et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. , 2006, Journal of the National Cancer Institute.

[8] G. Naglie,et al. The association between patient age and prostate cancer stage and grade at diagnosis , 2004, BJU international.

[9] F. Holmes,et al. Relationship of age to histologic grade in prostate cancer , 1990, The Prostate.